Stay updated with breaking news from Ramesh Narayanan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Day 3 of ID4Africa 2024 focused on integrating digital ID wallets with national systems, and how to ensureeffective governance frameworks are in place.
Patients continue to be enrolled in a study evaluating the dual-action androgen receptor inhibitor ONCT-534 for the treatment of patients with advanced prostate cancer who are relapsed or refractory to approved androgen receptor pathway inhibitors (ARPIs).
A drug candidate developed by researchers at the University of Tennessee Health Science Center for advanced metastatic castration-resistant prostate cancer is now in its first clinical trial.
Day 2 at GoaFest 2023 takes creativity and inspiration to new heights
Day 2 at GoaFest 2023 takes creativity and inspiration to new heights